Sign in

CIK 0001372299

  • Non-accelerated filer
  • Smaller reporting company

Ocugen, Inc.

Sign in to watch
Ticker
OCGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 484-328-4701
Business address
11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
Former names
HISTOGENICS CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,088,801
in 2 filings, $1.1M under 10b5-1 plans

Net −$1,088,801. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Musunuri Shankar −$1.1M Chief Executive Officer sold 51% of stake
Date Insider Transaction Shares Price Value Owned after
2023-01-03 Crespo Jessica CAO/SVP, Finance Shares withheld for taxes −1,913 $1.25 $2K 161,478
2023-01-03 Crespo Jessica CAO/SVP, Finance Grant or award +122,951 163,391
2023-01-03 Crespo Jessica CAO/SVP, Finance Grant or award · Option (Right to Buy) +147,638 147,638
2022-03-18 Crespo Jessica CAO/SVP, Finance Grant or award +22,940 40,440
2022-03-18 Crespo Jessica CAO/SVP, Finance Grant or award · Option (Right to Buy) +84,192 84,192

Page 1 of 1 · 5 trades